Ophthal Medical News about cost-effectiveness

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden
The European Journal of Health Economics, 08/04/09

Persson U et al. – Ex ante VBP assessment is a form of risk sharing, which has been used by TLV to speed up reimbursement and dispersion of effective new drugs despite uncertainty in their true cost–effectiveness. Manufacturers are often asked in return to generate additional health economic evidence that will establish cost–effectiveness as part of ex post review. The alternative is to delay the reimbursement approval until satisfactory evidence is available.

<< Previous
Measurement of AQCmax of Five Different Ophthalmic Solutions and...

Next >>
Efficacy and safety of prostaglandin analogues in patients with...

Economic evaluation of arthritis self management in primary care
British Medical Journal, 10/08/09 Relevance Score: 87%

Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis
Internal and Emergency Medicine, 11/10/09 Relevance Score: 84%

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
British Medical Journal, 10/08/09 Relevance Score: 84%

Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
PharmacoEconomics, 10/07/09 Relevance Score: 84%

Fine-needle aspiration of primary osseous lesions: A cost effectiveness study
Diagnostic Cytopathology, 10/06/09 Relevance Score: 84%